Should lowest-risk prostate 'cancer' still be called cancer? How changing the name could save lives. A growing number of prostate cancer experts argue that calling the lowest-risk prostate cancer "cancer" does more harm than good.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: A growing number of prostate cancer experts argue that calling the lowest-risk prostate cancer "cancer" does more harm than good. A new UCLA-led study found removing the cancer label could dramatically reduce overtreatment and encourage more men to get screened, potentially leading to significantly fewer deaths from aggressive prostate cancer.
- Ponto de atenção: should.
- Ponto de atenção: lowest.
- Ponto de atenção: risk.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.